To determine the safety and optimal dose of DNA/liposome compound when injected directly into colorectal cancers which have spread to the liver and to transfer this gene to the cancer cells in the liver thereby making them susceptible to destruction by the normal immune cells of the patient.
Showing the most recent 10 out of 1267 publications